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Abstract
Chiari malformation type I (CMI) is a disorder characterized by hindbrain overcrowding into an underdeveloped posterior
cranial fossa (PCF), often causing progressive neurological symptoms. The etiology of CMI remains unclear and is most likely
multifactorial. A putative genetic contribution to CMI is suggested by familial aggregation and twin studies. Experimental
models and human morphometric studies have suggested an underlying paraxial mesoderm insufficiency. We performed a
case-control association study of 303 tag single nucleotide polymorphisms (SNP) across 58 candidate genes involved in
early paraxial mesoderm development in a sample of 415 CMI patients and 524 sex-matched controls. A subgroup of
patients diagnosed with classical, small-PCF CMI by means of MRI-based PCF morphometry (n = 186), underwent additional
analysis. The genes selected are involved in signalling gradients occurring during segmental patterning of the occipital
somites (FGF8, Wnt, and retinoic acid pathways and from bone morphogenetic proteins or BMP, Notch, Cdx and Hox
pathways) or in placental angiogenesis, sclerotome development or CMI-associated syndromes. Single-marker analysis
identified nominal associations with 18 SNPs in 14 genes (CDX1, FLT1, RARG, NKD2, MSGN1, RBPJ1, FGFR1, RDH10, NOG, RARA,
LFNG, KDR, ALDH1A2, BMPR1A) considering the whole CMI sample. None of these overcame corrections for multiple
comparisons, in contrast with four SNPs in CDX1, FLT1 and ALDH1A2 in the classical CMI group. Multiple marker analysis
identified a risk haplotype for classical CMI in ALDH1A2 and CDX1. Furthermore, we analyzed the possible contributions of
the most significantly associated SNPs to different PCF morphometric traits. These findings suggest that common variants in
genes involved in somitogenesis and fetal vascular development may confer susceptibility to CMI.
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Introduction
The Chiari malformations, first described in 1895 [1], are a
group of disorders sharing the common feature of ectopia of the
cerebellar tonsils, which are downwardly displaced through the
foramen magnum. Chiari malformation type I (CMI) is currently
defined by the observation, on cranial midsagittal magnetic
resonance imaging (MRI), of a descent of the cerebellar tonsils
across the foramen magnum of at least 3 mm [2]. In contrast with
Chiari II and III malformations, in CMI the rest of hindbrain
structures remain within the posterior fossa.
CMI causes neurological dysfunction by direct compression of
the neural tissue at the craniovertebral junction or cerebrospinal
fluid disturbances that give rise to syringomyelia or hydrocephalus.
The most frequent symptoms are headache, ocular disturbances,
vertigo, sleep apnea and lower cranial nerve signs, including
tongue fasciculation, dysphagia or dysarthria. Motor and sensory
symptoms derived from spinal cord disturbances associated with
syringomyelia or scoliosis, [3,4] as well as signs and symptoms
mimicking pseudotumor cerebri are also often encountered.
Although presentation typically occurs in middle age, it may start
in childhood or infancy, where it is a cause of sudden infantile
death syndrome [5,6]. Conversely, cases of CMI can often be
asymptomatic and tonsillar descent is often regarded as an
incidental neuroradiological finding [7,8]. The prevalence of
CMI is estimated to be in the 1/1,000 to 1/5,000 range [9]. A
retrospective analysis of 22,591 serial cranial MRI studies, using a
conservative definition of cerebellar tonsillar herniation of
$5 mm, showed the presence of CMI in 0.77% of the subjects
and asymptomatic CMI in 0.11%, with an estimated prevalence of
1/1,280 [10].
Regarding pathogenesis, different mechanisms are to be
distinguished. In the classical form, a shallow posterior cranial
fossa (PCF) is unable to house a normal hindbrain and hence the
tonsillar herniation occurs (Figure 1A). Seminal experimental work
by Marin-Padilla and Marin-Padilla [11] demonstrated that
underdevelopment of the occipital bone and overcrowding of the
cerebellum in a small posterior fossa are the fundamental defects
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in CMI [12,13,14]. This has been underscored by several
radiological morphometric studies [3,15,16,17,18,19]. However,
cerebellar herniation may also occur in conditions such as cranial
settling associated with connective tissue disorders, intraspinal
hypotension following CSF leaks or lumboperitonial shunting,
cord traction in tethered cord syndrome and intracranial
hypertension caused by space-occupying lesions or hydrocephalus
[20], where the PCF has a normal size and the term ‘‘secondary’’
CMI is preferred. In the classical form of CMI there is shortness of
the basichondrocranium [3,15,16,17,19,20,21,22], suggesting un-
derdevelopment of occipital somites and pointing at insufficiency
of the paraxial mesoderm as the central event in CMI
pathogenesis [23].
Whether CMI mesodermal insufficiency is a primary (genetic)
condition or occurs as the result of early gestational injuries, or
even post-natal osseous growth disturbances [16] is unknown.
However, a number of evidences suggest that, at least in a subset of
CMI cases, genetic factors may play an important role, including
CMI familial aggregation [9,24], higher degree of concordance in
monozygotic twins and CMI occurrence as part of Mendelian
syndromes [25,26,27]. In the instance of Crouzon syndrome, a
specific FGFR2 mutation has been associated with CMI and
syringomyelia in a small series of cases [28] and a PAX2 mutation
was found in two siblings with CMI and coloboma [29]. The only
reported genome-wide linkage screen, performed in 23 CMI
multiplex families, uncovered two loci on chromosomes 9 and 15,
with maximal two-point LOD (logarithm of the odds) score of 3.3
on 15q [30]. To date, no single gene has been identified as causing
CMI.
If heredity does indeed play a role in CMI, it is also possible that
this may occur via a polygenic mechanism. Common genetic
variants in genes involved in growth and shaping of the PCF
should be among the first to be explored. A similar approach has
been used in association studies performed in patients with Chiari
malformation type II, where screening of genes critical for
neurulation and neural tube closure disclosed some risk factors
but no major causative gene (reviewed in [31]). In contrast, no
previous association study has been carried out in CMI. We here
sought to identify common variants associated with development
of CMI among critical genes expressed during occipital somite,
sclerotome and placental development.
Subjects and Methods
Ethics Statement
The present investigation was conducted according to the
principles expressed in the Declaration of Helsinki and was
approved by the Ethics Committee of the Vall d’Hebron
University Hospital. All participants signed an informed consent
prior to their participation in the study.
Subjects
A total of 415 patients (42.265.9 years) with symptomatic CMI
were recruited between 2004 and 2010. Three hundred and thirty
seven patients were diagnosed and treated at the Division of
Neurosurgery and the Pediatric Neurology Service of the Vall
d’Hebron University Hospital in Barcelona. In all of them
evaluation included direct anamnesis, physical exam, neurophys-
iological studies (somatosensory evoked potentials, brain auditory
evoked potentials and polysomnography) and a cranial and spinal
MRI study. For an additional 78 cases that were referred from two
Spanish CMI patient associations, review of clinical summaries,
radiological reports and telephone interviews were used to confirm
the diagnosis, but direct review of the MRI studies was not always
possible. Diagnosis of CMI was based on MRI demonstration of
downward herniation $3 mm of the cerebellar tonsils on a
midsagittal T1-weighted image in the presence of signs or
symptoms indicating neural compression at the craniovertebral
junction, syringohydromyelia, cerebellar dysfunction or intracra-
nial hypertension
Since recent studies have clearly demonstrated that various
mechanisms may lead to tonsillar herniation, we tried to identify
the subset of patients with small PCF in an attempt to increase
sample homogeneity. To this end we performed a morphometric
PCF analysis in 211 cases with available digital MRI studies
(Figure 1B). After applying a previously described logistic
regression model based on several PCF measurements performed
in CMI cases and a control population [32] we identified a
subgroup of 186 patients representative of classical CMI, i.e., with
underdeveloped PCF.
Clinical data was retrieved from an in-house patient database
devoted to Chiari malformations and related disorders, a clinical
research repository that included detailed information about the
medical history, family history, symptoms and signs, treatment and
any relevant associated conditions.
The control sample was composed of 524 healthy blood donors
(42.6614.4 years), sex-matched with the case sample and recruited
at Vall d’Hebron University Hospital in Barcelona. To minimize
Figure 1. Typical neuroradiological findings in CMI. A) T1-weighted mid-sagittal MR image showing downward herniation of the cerebellar
tonsils (a) and hypoplasia of the occipital components of the posterior cranial fossa (b): the supraocciput (c) and the basiocciput (d). B) Morphological
measurements performed: length of tonsillar descent (f), supraocciput (g-b) and clivus (c–d) and foramen magnum diameter (b–c). The antero-
posterior diameter of PCF (h) was inferred from a line running from the internal occipital protuberance (a) to top of the dorsum sellae (d). The PCF
area was estimated as the polygon delimited by (a) (b) (c) (d) and (e) and the osseus PCF area as the one delimited by (a) (b) (c) and (d). Angular
measurements: tentorium angle (i), basal angulation (j) and Wackenheim angle (k).
doi:10.1371/journal.pone.0057241.g001
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ethnic heterogeneity only Caucasian subjects of Spanish origin
were included in this study.
DNA isolation and Quantification
Genomic DNA was isolated from peripheral blood lymphocytes
by the salting-out method [33] and from saliva with Oragen DNA
Self-Collection kit according to the manufacturer’s recommenda-
tions (Genotek Inc. Ottawa, Ontario, Canada). DNA concentra-
tions of all samples were determined on a NanoDrop spectropho-
tometer (NanoDrop Technologies, LLC, Wilmington, DE).
Selection of genes and SNPs
We selected 58 functional candidate genes. Most belonged to
gene pathways involved in the early paraxial mesoderm develop-
ment, leading to formation of the occipital somites, such as retinoic
acid (RBP4, RBP1, STRA6, ADH4, RDH10, CRABP1, CYP26A1,
CYP26C1, RARG, RARA, RXRA, ALDH1A2) reviewed in [34],
FGF8 (FGF8, FGFR1, DUSP4, HES7, SNAI1, SNAI2, CDH1)
[35,36,37], Wnt (WNT3A, CTNNB1, Axin2, T, TBX6, MSGN1,
NKD1, NKD2) [38,39,40], Notch (DLL1, RBPJ, LFNG, NOTCH1,
MESP2, ID1, ID2) [37,40], bone morphogenetic proteins
(BMPR1A, BMP2) [41], Cdx (CDX1) [39,42] and Hox pathways
(HOXA1, HOXA2, HOXA3, HOXA4, HOXB1, HOXB2, HOXB3,
HOXB4, HOXC4, HOXD1, HOXD3, HOXD4) reviewed in [42]. In
addition, genes involved in sclerotome development, chondrogen-
esis and osteogenesis (NOG, SHH, NKX3-2, PRRX1) [43,44,45,46],
genes from the VEFG family crucial for placental angiogenesis
(VEGFA, KDR, FLT1) [47,48] and genes responsible for two
conditions frequently associated with CMI, NF1 (neurofibromato-
sis) and STAT3 (Hyper-IgE Syndrome), were also included
[49,50].
The SNP selection was based on genetic coverage criteria, by
considering linkage disequilibrium (LD) patterns within the
candidate genes [51]. SNPs covering each gene plus 5 Kb flanking
sequences were picked from the CEU panel of the HapMap
database (www.hapmap.org, phases 1+2+3, release 27) [52,53].
We used the LD-select software (droog.gs.washington.edu/ldSe-
lect.html) to evaluate LD of the genomic regions in order to
minimize redundancy between the selected SNPs [54,55].
TagSNPs were selected with the following criteria: r2,0.85 from
any other SNP according to CEU HapMap data and a minor
allele frequency (MAF).0.10 for genes with less than 20 tag SNPs
and MAF.0.25 for those genes with more than 20 tagSNPs
(FLT1, KDR, NOTCH1, RXRA).
Plex design, genotyping and quality control
A total of 384 tagSNPs were initially selected in our study (Table
S1): 77 SNPs for the retinoic acid pathway, 44 SNPs for the FGF8
pathway, 55 SNPs for the Wnt pathway, 44 SNPs for the Notch
pathway, 24 SNPs for BMP, 6 SNPs for CDX, 38 SNPs for Hox
pathways, 30 SNPs for genes involved in sclerotome development,
51 SNPs for the VEGF pathway and 15 SNPs for NF1 and STAT3.
Genotyping was performed at the Barcelona node of the
National Genotyping Center (CeGen, www.cegen.org) using the
VeraCode technology (Illumina, San Diego, CA, USA) [56]. A
total of 9 HapMap individuals were included as controls in the
genotyping assay, obtaining a 100% concordance rate with
HapMap genotype data. In addition, no differences were found
in the genotypes of thirteen replicates.
Statistical analysis
The analysis of minimal statistical power was performed a priori
with the CaTS Power Calculator software (sph.umich.edu/csg/
abecasis/CaTS) [57], assuming an odds ratio (OR) of 1.5,
estimated disease prevalence of 0.008 [7,10,24], significance level
of 0.05 (a) and MAF of 0.10, under the additive model.
All individuals with genotyping rates under 80% were excluded
from the study. From 384 SNPs genotyped in our study, 303
passed quality controls filters and were included in the analysis,
whereas 81 (21%) were excluded for the following reasons: more
than 15% missing genotypes, deviation from Hardy-Weinberg
equilibrium (HWE threshold set at p = 0.01 in our control
population), monomorphism, MAF,0.10 or MAF,0.25 and
r2.0.85 from any other studied SNP in our control sample. The
evaluation of LD patterns and r2 were performed from the
genotype data of controls using Haploview v4.2 [58].
Single-marker analysis. The analysis of HWE and the case-
control association study were performed with the SNPassoc R
package [59]. For the case-control study we analysed all single
markers under the additive model using the Cochran-Armitage
Trend Test (ATT) (Table S1). A quantile-quantile plot (Q-Q plot)
was generated with the ggplot2 R library [60]. The correction for
multiple testing was performed using the Q-value R library
assuming a 10% False Discovery Rate (FDR) [61] and the
Bonferroni correction.
Multiple-marker analysis. To minimize multiple testing
and type I (a) errors, we restricted the haplotype-based association
study to only those LD blocks that included the SNPs overcoming
the 10% FDR correction.
The linkage disequilibrium patterns for CDX1, ALDH1A2 and
FLT1 were constructed from the genotyping data of our control
individuals, using Haploview v4.2 software [58]. The haplotype-
based analysis was performed using the same software [58]. To
obtain a measure of significance for multiple testing in haplotype
analysis, a total of 10,000 permutations were performed.
Haplotypes with frequencies ,0.05 were excluded.
PCF morphometric traits and risk genotypes. We used
the Scheffe´’s post hoc test to evaluate whether common variants
contributed to variation in any specific parameters as measured in
PCF morphometric analyses, including cerebellar tonsillar descent,
length of supraocciput, length of the clivus, foramen magnum
diameter, PCF area, osseous PCF area, antero-posterior diameter
of the PCF (PCF length), tentorium angle, basal angulation and
Wackenheim angle, as previously described [32]. The analysis was
carried out only in the 186 patients where the PCF morphometry
confirmed the diagnosis of classical CMI and was limited to
markers overcoming 10% FDR corrections for multiple testing in
the single-marker analysis. The Kruskal-Wallis nonparametric test
was used for variables not normally distributed (Kolmogorov-
Smirnov test P,0.05) or showing no homogeneity of variances
(Levene’s test P,0.05)).
Results
The most common signs and symptoms in the 415 cases
included in the study are listed in Table 1. Headache was the most
prevalent symptom (69.1%), often featuring neck irradiation
(43.3% of those with headache), followed by dizziness (35.1%),
motor weakness (33.6%), instability (32.1%), upper limb paresthe-
sias (30.7%), sensory loss (29.7%) and fatigue (28.1%). Syringo-
myelia was present in 35.1% of cases. Hydrocephalus (15.1%)
required specific management. Other, less common manifesta-
tions, as well as co-morbid conditions, were typical for CMI
(Table 1). Positive CMI family history, defined as at least one
MRI-confirmed CMI first relative, was present in only 6% of the
cases. Surgical PCF reconstruction was performed in 55.8% of
patients.
Chiari I Malformation Genetic Association Study
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Criteria for surgery were a .3 mm descent of the cerebellar
tonsils in i) symptomatic patients, ii) oligosymptomatic patients
with sleep apnea syndrome predominantly of the central type, and
iii) patients with syringomyelia. Posterior fossa reconstruction was
carried out in all patients to restore the volumetric capacity of the
posterior fossa and to restore normal CSF dynamics at the
craniovertebral junction. In summary, the technique consisted of
the removal of a large amount of occipital bone and the posterior
arch of the atlas. The dura mater was opened and in most cases an
extra-arachnoidal technique was used. An extensive dural graft
secured with tenting sutures to the cervical fascia was used to avoid
arachnoid scarring and to allow for the expansion of the
compressed cisterna magna or the creation of a pseudocisterna
magna
Initially, 384 SNPs from 58 candidate genes were genotyped
(Table S1). Eighty-one SNPs were excluded from statistical
analysis after data filtering: 40 SNPs had a genotyping rate below
85%, 4 SNPs showed deviation from HWE, 20 SNPs were
monomorphic or had MAF,0.10 (or MAF,0.25) and 17 had a
r2.0.85 with other SNPs in the same candidate gene (Table S1).
All individuals with genotyping rates below 80% were excluded
from the study, resulting in a range of genotyping efficiency of 94–
97%. Thus, 303 SNPs were finally assessed in the association study
in a total of 404 patients (286 female) and 519 sex-matched
controls. The minimal statistical power of our sample, under the
additive model, was 78% for the whole sample and 53% after
subgrouping into classical CMI.
Single Marker Analysis
We used a two-tiered single marker analysis. The first step
comprised the whole patient sample while the second one included
the more homogeneous subset of morphometry-proven classical
CMI patients. In both we used the same control population.
The case-control association study with the whole CMI sample
(404 patients and 519 controls) found nominal associations (P-
values,0.05) for 18 SNPs located in 14 genes (Table S1). Only 5
SNPs, located in three different genes, displayed P-values,0.01:
CDX1 (rs887343, rs2282809), FLT1 (rs17086609) and RARG
(rs1554753, rs6580936) (P-values and genotype counts are shown
in Table 2 and Figure 2A, and P-values for the remaining SNPs
are shown in Table S1). However, no marker remained significant
after applying 10% FDR or the Bonferroni correction (P
value = 1.6E-04 ( = 0.05/303 SNPs)).
The second analysis considered 186 classical CMI patients
(patients with MRI morphometry-confirmed small PCF) and the
519 controls. Nominal associations (P-values,0.05) were found
under the additive model for 26 SNPs located in 13 genes (Table
S1). The following 10 SNPs, located in 6 different genes, displayed
P-values,0.01: ALDH1A2 (rs2899611, rs6493979, rs2067062),
BMPR1A (rs12415784), CDX1 (rs887343, rs2282809), FLT1
(rs17086609, rs9554320), MSGN1 (rs11689375) and RDH10
(rs16938610) (Table 2 and Figure 2B). P-values for the remaining
SNPs are shown in Table S1.
After applying a 10% FDR correction (P,2.09E-03) four
associations did remain significant: rs887343 (P=4.4E-04) in
CDX1, rs17086609 (P=1.37E-03) in FLT1, rs2899611 (P=2.01E-
03) and rs6493979 (P=2.09E-03) in the ALDH1A2 gene. Under
the more strict Bonferroni correction no SNP reached significance.
Multiple Marker Analysis
The haplotype analysis was addressed only for those genes
containing SNPs that passed 10% FDR in the single marker
analysis. The pairwise linkage disequilibrium map of ALDH1A2,
CDX1 and FLT1 genes was calculated in the sample under study
(Figure 3). LD patterns across the FLT1 gene defined five blocks
(block 1 of ,1 kb: rs9551462, rs9554325; block 2 of 6 kb:
rs17086617, rs9508021 and rs2104330; block 3 of 1 kb:
rs11149523 and rs8002446; block 4 of 22 kb: rs9513112,
rs9513114 and rs7330109; block5 of 5 kb: rs12858139 and
rs677471); two blocks were defined in ALDH1A2 (block 1 of
11 kb: rs3784264, rs3784260, rs4646615; block 2 of 17 kb:
Table 1. Clinical findings in 415 patients with Chiari
malformation type I.
CMI
Number of patients 415
Sex (M/F) 122/293
Age (y) 42.2650.9
Age at diagnosis 30.6658.7/323
Hydrocephalus 57/377 (15.1%)
Syringomyelia 133/379 (35.1%)
Intracranial Hypertension 20/376 (5.3%)
Retrocurved Odontoid 40/352 (11.4%)
Basilar impression 11/382 (2.3%)
Platibasia 8/382 (2.1%)
Klippel-Feil Malformation 3/377 (0.8%)
Other Craniocervical
Malformations
24/377 (6.4%)
SIGNS AND SYMPTOMS
Time elapsed from onset (mo) 113.3659.4/323
Headache 246/356 (69.1%)
Occipital Headache/Cervicalgia 97/224 (43.3%)
Cough Headache 87/358 (24.3%)
Dizziness 128/365 (35.1%)
Vertigo 82/365 (22.5%)
Visual Alterations 71/364 (19.5%)
Nystagmus 41/276 (14.8%)
Kyphoscoliosis 30/160 (18.7%)
Fatigue 102/363 (28.1%)
Instability 117/364 (32.1%)
Sensory Loss 108/364 (29.7%)
Motor Weakness 123/366 (33.6%)
Dysphagia 67/365 (18.3%)
Dysphonia 16/365 (4.4%)
Gait Disturbances 73/364 (20.0%)
Paresthesia Upper Limbs 112/365 (30.7%)
Paresthesia Lower Limbs 47/366 (12.9%)
Upper Limb Pain 47/365 (12.9%)
Lower Limb Pain 16/365 (4.4%)
Neck Pain 169/366 (46.2%)
Difficulty Swallowing 66/365 (18.1%)
Anxiety 38/360 (10.5%)
Depression 33/361 (9.1%)
Neurofibromatosis type 1 45/382 (11.8%)
TREATMENT
Posterior fossa reconstruction 210/376 (55.8%)
doi:10.1371/journal.pone.0057241.t001
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rs4238326, rs6493979, rs4238328, rs2067062 and rs7169439) and
only one block in CDX1 (block 1 of 2 kb: rs887343 and
rs2282809). The haplotype analysis was assessed only for those
blocks containing SNPs significantly associated (block2 of
ALDH1A2 and the only block of CDX1) (Figure 3). The SNPs
rs2899611 (in ALDH1A2) and rs17086609 (in FLT1) were
singletons (Figure 3). The results in the CDX1 gene identified a
risk haplotype constituted of G-G allelic combination (Permutated
P-value = 9.4 E-03; OR=1.54, 95% CI= 1.19–2.01) (Table 3).
The results in the ALDH1A2 gene identified an over-representa-
tion of the C-A-G-C-G haplotype in cases (Permuted P-
value = 0.0179; OR=1.53, 95% CI= 1.16–2.02).
PCF morphometric traits and risk genotypes
We sought to identify a possible relationship between genotypes
of the four SNPs in three genes that passed 10% FDR correction
(rs289961, rs6493979 (ALDH1A2), rs887343 (CDX1), rs17086609
(FLT1)) and any of the PCF morphological measurements
performed on the MRI studies of 211 patients (Table 4). A
modest association was found between the two SNPs in ALDH1A2
and the Wackenheim angle and the degree of basal angulation (P-
value,0.05).
Discussion
In the present association study performed in a sample of CMI
patients from the Spanish population we found nominal associ-
ation for SNPs in several genes involved in the early development
of paraxial mesoderm and vascular development of the placenta.
After corrections for multiple testing, only associations with four
SNPs within CDX1, FLT1 and ALDH1A2 remained significant in
the subsample where MRI morphometric analysis documented a
reduced PCF. Considering these four SNPs, we also found a
modest correlation between the two in ALDH1A2 and specific
morphometric data of the PCF.
The Chiari malformations have long been considered sporadic
conditions, without a heritable etiology. However, there have been
a number of case reports identifying familial aggregation and
clustering of CMI, suggesting a genetic basis [9,25] although the
involved genes and even type of inheritance are presently
unknown. Given the predominance of apparently sporadic
patients and the relatively high prevalence of the disorder, a
polygenic model of inheritance seems plausible in a majority of
CMI cases. To our knowledge, however, this is the first genetic
association study ever to be carried out in CMI.
The contribution of common genetic variants has been
examined in Chiari malformation type II (CMII), where several
studies failed to demonstrate consistent associations with develop-
mental genes such as CRABP1, CRABP2, ALDH1A2, RALDH2,
CYP26, HOX, NOG, SHH and TBX6 (reviewed in [62,63,64]).
Mutational screens of some of these genes did not find definitive
evidence for disease-causing mutations [63]. Since the most
accepted pathogenic hypothesis in CMI is that of insufficiency of
paraxial mesoderm in the third and fourth week of gestation, we
decided to explore whether variants in genes expressed during
somitogenesis could be associated with the milder and more
frequent CMI phenotype.
Association study results
A number of nominal associations were found in the whole CMI
sample. Despite none of them overcoming corrections for multiple
testing, three of the selected candidate genes, CDX1, FLT1 and
RARG, contained SNPs that showed association with P-val-
ues,0.01, thus suggesting that these genes are worth of scrutiny
in further samples. However, our cohort was selected according to
the radiographic standard criterion for diagnosis of CMI, a
cerebellar tonsillar descent exceeding 3 mm on midsagittal MRI.
Application of this single criterion may have resulted in clinical
(and presumably genetic) heterogeneity, as in fact is suggested by
the PCF morphometric data we obtained in the subgroup of cases
where digitized MRI studies were available. Thus, it is not
Figure 2. Quantile-quantile plot of the 303 P-values obtained in the association study under the additive model. 404 CMI patients
versus 519 controls (A), and 186 small-PCF CMI versus 519 controls (B). SNPs with P-value,0.01 are indicated. Asterisks denote SNPs displaying
association after 10% FDR correction for multiple testing (P,2.09E-03).
doi:10.1371/journal.pone.0057241.g002
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surprising that statistical significance of the association was higher
in the group of 186 patients with underdeveloped PCF. Among the
26 nominally associated SNPs within 13 genes, in this ‘‘classical
CMI’’ subsample, association with P-values,0.01 were found for
SNPs within six genes: ALDH1A2, RDH10, CDX1, BMPR1A,
MSGN1 and FLT1. The association remained significant after a
10% FDR correction for SNPs within three genes: rs887343 in
CDX1, rs17086609 in FLT1 and rs2899611 plus rs6493979 in the
ALDH1A2 gene.
Regarding the potential functional relevance of the identified
variants, four of the genes with the best association signals (P,0.01
in the single marker analysis of either CMI or classical CMI),
ALDH1A2, RDH10, RARG and CDX1, are directly or indirectly
related with retinoic acid (RA) signalling during somitogenesis. RA
is a transcription factor needed for elongation of the embryonic
body axis, acting as a molecular oscillator in the somitic precursors
of the paraxial mesoderm [39] and promoting somite differenti-
ation through regulation of the Hox genes [42]. Expression of RA
synthetic enzyme, RALDH2, encoded by ALDH1A2, is crucial at
these presomitic or early somatic stages. Avian or mouse RA-
deficient embryos develop abnormally small somites (reviewed in
[34]), while exposure to teratogenic RA levels give rise to
congenital dysraphism in humans [65]. RDH10 encodes a retinol
dehydrogenase critical for embryonic vitamin A metabolism.
Murine Rdh10 mutants display lethal abnormalities characteristic
of a RA-deficiency phenotype [66]. RARG binds to DNA after
heterodimerization with any of the retionid X receptors, leading to
activation of RA response elements (RAREs), which displace
transcriptional corepressors and recruits coactivators [67].
Through this pathway, RA regulates specific Hox expression in
paraxial mesoderm, determining embryonic anterior-posterior
patterning throughout somitogenesis (reviewed in [34,67]). This
may origin spinal column defects such as scoliosis [68], present in
nearly 20% of our CMI patients. A third RA-related gene showing
association is CDX1. Cdx genes encode homeodomain transcrip-
tion factors containing atypical RARE [69,70]. In the mouse
embryo primitive streak, expression of Cdx1 begins at postconcep-
tional day 7.5 in concurrence with onset of RA signalling and Hox
expression. Of note, Cdx1-null mutants display alterations in the
basioccipital bone [69].
The other three listed genes, BMPR1A, MSGN1 and FLT1,
belong to less interrelated pathways. BMPR1A has been found to
regulate the recruitment of prospective paraxial mesoderm cells in
the mouse epiblast. Mutant embryos have a shorter primitive
streak, a more proximal node and a defective extension of the
primitive streak [41]. MSGN1 is a direct target of Wnt and TBX6
during the specification, maturation and segmentation of the
paraxial mesoderm in the mouse [38]. FLT-1 encodes VEGFR-1,
a vascular endothelial growth factor receptor expressed in the
endothelium of blood vessels [71]. Vasculogenesis at the chorionic
villi tree is evident by post conceptional day 21, during the four-
somite embryonic stage (reviewed in [72]). A FLT-1 mutation
resulted in endothelial disorganization and abnormal vessel
formation during early embryo development [73]. During the
fourth week of life the human embryo switches from the exchange
of nutrients and wastes by simple diffusion to establishment of
utero-placental circulation. It is conceivable that failure to
properly transition through these two stages could impair critical
processes as mesodermal proliferation or neurulation.
Finally, the four variants associated with classical CMI
(rs887343 in CDX1, rs17086609 in FLT1 and rs2899611 plus
rs6493979 in ALDH1A2) are intronic, with no direct effect on the
protein sequence. It could be that the identified risk variants may
produce by themselves functional alterations or they might lie in
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Figure 3. Haploview graphs showing the markers tested and haplotype blocks constructed for ALDH1A2, CDX1 and FLT1. D9 values are
indicated (tones from white to dark grey indicate D9 values from 0 to 1, respectively). The genomic structures of ALDH1A2, CDX1 and FLT1 genes are
drawn with coding exons indicated as black boxes. The SNPs with P-value,0.01 are indicated with an asterisk (*); the SNPs showing association after
10% FDR correction for multiple testing (P,2.09E-03) are indicated with a double asterisk (**).
doi:10.1371/journal.pone.0057241.g003
Table 3. Haplotype analysis for the linkage disequilibrium blocks containing SNPs that showed significant associations in the
single marker analysis (Haploview v4.2 software).
Population Gene LD block: SNPs Haplotype Cases % Controls %
P-value
(permP)a Odds Ratio [95% CI]
Classical CMI CDX1 Block 1: rs887343-rs2282809 GG 255 (71) 614 (62) 0.0014 (0.0094) 1.54 [1.19–2.01]
CA 103 (29) 384 (38) 0.0012 (0.0092) 0.65 [0.50–0.84]
Classical CMI ALDH1A2 Block 2: rs4238326-rs6493979-
rs4238328-rs2067062-rs7169439
TGGAG 99 (28) 328 (33) 0.0732 (0.3975) 0.79 [0.60–1.02]
CAGCG 100 (28) 201 (20) 0.0025 (0.0179) 1.53 [1.16–2.02]
TGAAG 66 (19) 233 (24) 0.0563 (0.3233) 0.75 [0.55–1.01]
CAGCA 49 (14) 140 (14) 0.882 (1.0000) 0.97 [0.69–1.38]
TAGCG 38 (11) 87 (9) 0.2624 (0.8997) 1.24 [0.83–1.86]
aA total of 10,000 permutations were performed using Haploview v4.2 to obtain a measure of significance corrected for multiple testing.
doi:10.1371/journal.pone.0057241.t003
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LD with other susceptibility loci, in the case of an indirect
association. Since all these SNPs are tagSNPs, we analyzed these
variants and those in LD with them by means of the web utility
SNP Function Prediction [74]. The predictions of functional
effects for transcription factor binding sites, exonic splicing
enhancers or silencers, changing of splicing pattern or efficiency
by disrupting splice sites, regulation of protein translation by
affecting microRNA binding sites and conservation scores were all
negative.
Genetic-morphometric analysis
We also investigated whether any specific PCF morphological
feature might relate to any of the gene variants showing
association with CMI. A short anteroposterior diameter of the
PCF and an increased basal angle have been described in some
CMI morphometric studies [17,19]. However, no correlation was
found among genotypes and any of the previously considered
more typical features of CMI, such as clivus or supraocciput
length, PCF area or tentorial angle [15]. In our study, two SNPs in
ALDH1A2 displayed a correlation with the Wackenheim angle and
one of them with the basal angulation, in keeping with previous
evidence pointing at basiocciput, rather than supraocciput,
abnormalities in CMI. Whether an abnormal clivus slope does
constitute a marker of genetically-determined CMI deserves
further investigation.
Methodological issues
The present case–control association study raises several
methodological questions. First, the modest sample size (404
patients and 519 controls) may have prevented from detecting
subtle phenotypic effects, as the statistical power calculated for this
cohort is close to 80% when an OR of 1.5 is assumed. Second, we
do not present a replication study of our findings in an
independent cohort. This notwithstanding, ours was a relatively
large sample considering the low prevalence of CMI (1:1000 to
1:5000), bordering that of rare diseases. It was also the first CMI
sample being explored for association with a large set of candidate
genes. Third, although the SNP selection was designed to cover
the 58 candidate genes on the basis of existing linkage
disequilibrium patterns, gaps still exist in 12 genes due to
experimental constraints, and 21% of the 384 SNPs could not
be studied. Last, lack of MRI studiy of the control population may
have resulted in inclusion of some asymptomatic CMI cases,
although given the estimated low prevalence of tonsillar descent,
this should not be expected to influence the validity of our findings
In conclusion our genetic data give support to the hypothesis
that variants in genes involved in paraxial mesoderm may
determine PCF size to the extent of the development of the
CMI. Specifically, our results point to a putative role for defective
RA signalling and fetal vasculogenesis in causing hypoplasia of the
basichondrocranium. Although confirmatory studies are needed,
these are among the first genetic susceptibility factors to be defined
in CMI. Given the limitations of the current radiographic
diagnostic criteria, understanding of the genetic underpinnings
of CMI should have important clinical implications, including
earlier recognition of subjects at risk of becoming symptomatic and
the timely indication of the surgical reconstruction of the PCF.
Supporting Information
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